SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma
Our study demonstrated that <i>SGO2</i> was up-regulated in pan-cancers including LUAD and its high expression was strongly associated with poor overall survival (OS) and progression-free survival (PFS) of patients with LUAD. <i>SGO2</i> promoted cell proliferation, cell migration, invasion and EMT of A549 cells. Additionally, <i>E2F1</i> was involved in regulation of cell cycle and cell proliferation mediated by <i>SGO2</i>. This research elucidated the oncogenic significance of <i>SGO2</i> in LUAD, proposing its potential as a prognostic biomarker and a promising target for therapeutic interventions.
Authors
- Tingxiu Xiang (ORCID: https://orcid.org/0000-0003-4589-0599)
- Yinghua Chen (ORCID: https://orcid.org/0000-0003-2295-7228)
Institutions
- Chongqing University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2024-08-30
- DOI
- https://doi.org/10.31083/j.fbl2909314
- Citations
- 2
- Primary Topic
- Phytochemical Studies and Bioactivities
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Natural Science Foundation of China
- Chongqing Science and Technology Commission